Signal sequence that induces protein secretion in intestinal microbiome
US-2024190925-A1 · Jun 13, 2024 · US
US9365873B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9365873-B2 |
| Application number | US-201514753191-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 29, 2015 |
| Priority date | Aug 11, 2014 |
| Publication date | Jun 14, 2016 |
| Grant date | Jun 14, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides genetically engineered microorganisms with altered carbon monoxide dehydrogenase (CODH) activity and methods related thereto. In particular, the invention provides a genetically engineered carboxydotrophic acetogenic bacterium having decreased or eliminated activity of CODH1 and/or CODH2. In certain embodiments, the bacterium may also have increased activity of CODH/ACS. The invention further provides a method for producing a product by culturing the bacterium in the presence of a gaseous substrate comprising one or more of carbon monoxide, carbon dioxide, and hydrogen.
Opening claim text (preview).
The invention claimed is: 1. A genetically engineered carboxydotrophic acetogenic bacterium having decreased or eliminated activity of CODH1 and/or CODH2 compared to a parental bacterium. 2. The bacterium of claim 1 , wherein the bacterium comprises at least one disruptive mutation in a CODH1 gene and/or CODH2 gene. 3. The bacterium of claim 2 , wherein the disruptive mutation decreases or eliminates expression of the CODH1 gene and/or the CODH2 gene compared to a parental bacterium. 4. The bacterium of claim 2 , wherein the disruptive mutation is a knockout mutation. 5. The bacterium of claim 1 , wherein the bacterium additionally has increased activity of CODH/ACS compared to the parental bacterium. 6. The bacterium of claim 5 , wherein the bacterium overexpresses a CODH/ACS gene compared to the parental bacterium. 7. The bacterium of claim 1 , wherein the bacterium produces one or more of ethanol and 2,3-butanediol. 8. The bacterium of claim 1 , wherein the bacterium produces a higher amount of ethanol, produces a lower amount of acetate, has a shorter lag phase, and/or has a higher growth rate compared to the parental bacterium. 9. The bacterium of claim 1 , wherein the bacterium consumes a gaseous substrate comprising one or more of CO, CO 2 , and H 2 . 10. The bacterium of claim 1 , wherein the parental bacterium is Clostridium autoethanogenum, Clostridium ljungdahlii , or Clostridium ragsdalei. 11. A method for producing a product, comprising culturing the bacterium of claim 1 in the presence of a gaseous substrate comprising one or more of CO, CO 2 , and H 2 , whereby the bacterium produces a product. 12. The method of claim 11 , wherein the bacterium comprises at least one disruptive mutation in a CODH1 gene and/or CODH2 gene. 13. The method of claim 12 , wherein the disruptive mutation decreased or eliminates expression of the CODH1 gene and/or the CODH2 gene compared to a parental bacterium. 14. The method of claim 12 , wherein the disruptive mutation is a knockout mutation. 15. The method of claim 11 , wherein the bacterium additionally has increased activity of CODH/ACS compared to the parental bacterium. 16. The method of claim 15 , wherein the bacterium overexpresses a CODH/ACS gene compared to the parental bacterium. 17. The method of claim 11 , wherein the product comprises one or more of ethanol and 2,3-butanediol. 18. The method of claim 11 , wherein the bacterium produces a higher amount of ethanol, produces a lower amount of acetate, has a shorter lag phase, and/or has a higher growth rate compared to the parental bacterium. 19. The method of claim 11 , wherein the parental bacterium is Clostridium autoethanogenum, Clostridium ljungdahlii , or Clostridium ragsdalei.
Butanols · CPC title
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title
with microorganisms other than yeasts · CPC title
polyhydric · CPC title
Biofuels, e.g. bio-diesel · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.